Control-IQ Technology Provides Similar Glycemic Outcomes Across Two Different Continuous Glucose Monitoring Sensors
Authors' conclusion
Control-IQ-based pump users experienced similar outcomes and achieved excellent glycemic control with G6 or G7 sensors.
Study context
- Population
- t:slim X2 insulin pump customers using Control-IQ technology who transitioned from G6 to G7 sensors
- Exposure
- Control-IQ technology with G7 vs G6 sensors
- Outcome
- Median times in glucose ranges
- Follow-up
- Final 30 days of G6 use vs initial 30 days of G7 use
Methodological detailsreal-world customer data, within-user comparison
- Real-world customer data
- Within-user comparison
Main finding
As reported in the abstract
- Median times in various glucose ranges changed by <1% and remained within consensus targets for TIR (70-180 mg/dL) >70% and TBR (<70 mg/dL) <4%
Observational data: associations, not effects.
Further findings
- Differences in sensor use, time in closed loop and median glucose were clinically insignificant
Original publication
Control-IQ Technology Provides Similar Glycemic Outcomes Across Two Different Continuous Glucose Monitoring Sensors. J Diabetes Sci Technol. Published 31 March 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →